Assura PLC Annual Report & Notice of AGM (3925B)
02 June 2023 - 4:00PM
UK Regulatory
TIDMAGR
RNS Number : 3925B
Assura PLC
02 June 2023
2 June 2023
Assura plc
Annual Report & Notice of AGM
Assura plc ("Assura"), the leading primary care property
investor and developer, is pleased to announce that the Annual
General Meeting ("AGM") will be held on Thursday 6 July 2023 at
11am BST.
The Annual Report and Accounts for the year ended 31 March 2023
and the Notice of AGM will be posted to shareholders today.
In accordance with Listing Rule 9.6.1, copies of these documents
have also been submitted to the UK Listing Authority via the
National Storage Mechanism and will be available for viewing
shortly at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
and can also be found on the Company's website at
http://assuraplc.com/investor-relations/reports-and-presentations/
.
Shareholders will be able to watch the AGM over the online
Investor Meet Company platform by registering in advance via the
following link:
https://www.investormeetcompany.com/assura-plc/register-investor
Shareholders are invited to submit any questions in respect of
the business of the AGM for the Board to consider. Questions may be
submitted in advance over the Investor Meet Company platform
following registration and the Board will aim to respond to any
such questions relevant to the business of the AGM. Further
information is set out in the Notice of AGM.
Shareholders wishing to vote at the AGM are strongly encouraged
to do so by completing a Form of Proxy as appropriate. Shareholders
will not be able to vote at the meeting over the online
platform.
- ENDS -
Assura plc Tel: 01925 945354
Orla Ball, Company Secretary E mail: Investor@assura.co.uk
David Purcell, Investor Relations
Director
FGS Global Tel: 0207 251 3801
Gordon Simpson Email: Assura@fgsglobal.com
James Thompson
Notes to Editors
Assura plc is a national healthcare premises specialist and UK
REIT based in Warrington, UK - caring for more than 600 primary
healthcare buildings, from which over six million patients are
served.
A constituent of the FTSE 250 and the EPRA* indices, as at 31
March 2023, Assura's portfolio was valued at GBP2.7 billion.
At Assura, we BUILD for health. Assura builds better spaces for
people and places, invests in skills and inspires new ways of
working, and unlocks the power of design and innovation to deliver
lasting impact for communities - aiming for six million people to
have benefitted from improvements to and through its healthcare
buildings by 2026.
Assura is leading for a sustainable future, targeting net zero
carbon across its portfolio by 2040.
Further information is available at www.assuraplc.com
*EPRA is a registered trademark of the European Public Real
Estate Association.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOAEALKFEFXDEFA
(END) Dow Jones Newswires
June 02, 2023 02:00 ET (06:00 GMT)
Assura (LSE:AGR)
Historical Stock Chart
From Apr 2024 to May 2024
Assura (LSE:AGR)
Historical Stock Chart
From May 2023 to May 2024